highly significantP < 0.001
To identify CpGs with highly significant tumor subtype-specific changes, stringent cut-offs ( P < 0.001 and Δb >0.20) were set for methylation-level changes relative to controls for each tumor subtype.
To identify CpGs with highly significant tumor subtype-specific changes, stringent cut-offs ( P < 0.001 and Δb >0.20) were set for methylation-level changes relative to controls for each tumor subtype.